Peritoneal Carcinomatosis Clinical Trials

125 clinical trials for Peritoneal Carcinomatosis across international registries, including 27 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis — RECRUITING · NA
• Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies — RECRUITING · PHASE1
• PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer — RECRUITING · PHASE1
• Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction — RECRUITING · PHASE2
• Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity — RECRUITING · PHASE2
• Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer — RECRUITING · PHASE2
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer — RECRUITING · PHASE1
• A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery — RECRUITING · PHASE2
• Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) — RECRUITING · PHASE2
• Intensification Treatment of Ovarian Cancer by PIPAC — RECRUITING · PHASE2
• Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) — RECRUITING · NA
• Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC — RECRUITING · PHASE2
• Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining) — RECRUITING · PHASE2
• PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis — RECRUITING · PHASE1
• Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer. — RECRUITING · NA
• A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer — RECRUITING · PHASE1
• Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis — RECRUITING · NA
• Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer — RECRUITING
• Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis — RECRUITING · NA
• Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) — RECRUITING · PHASE4
• Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed — RECRUITING
• Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis — RECRUITING · NA
• Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients — RECRUITING · PHASE2
• Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses — RECRUITING
• Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- — RECRUITING · NA
• A DOSE-RANGING STUDY OF IPH2201 IN PATIENTS WITH HIGH GRADE SEROUS CARCINOMA OF OVARIAN, FALLOPIAN TUBE OR PERITONEAL ORIGIN — RECRUITING
• PHASE 1B STUDY OF EXTENDED DOSING OF AN IMMUNOTHERAPEUTIC VACCINE, DPX-SURVIVAC WITH LOW DOSE CYCLOPHOSPHAMIDE IN PATIENTS WITH SURGICALLY OPERABLE OR ADVANCED STAGE OVARIAN FALLOPIAN TUBE OR PERITONEAL CANCER — RECRUITING · PHASE1
• MANAGEMENT OF PRIMARY AND SECUNDARY PERITONEAL CARCINOMATOSIS FROM COLO-RECTAL CANCER, RECURRENT OVARIAN CANCER AND ABDOMINAL SARCOMATOSIS BY CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY — ACTIVE_NOT_RECRUITING · PHASE2
• Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Galunisertib Combined With Capecitabine in Advanced CRC With PM — ACTIVE_NOT_RECRUITING · PHASE1
• Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis — COMPLETED · PHASE2
• Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer — COMPLETED · PHASE1
• MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial). — NOT_YET_RECRUITING · PHASE2
• Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis — TERMINATED · PHASE2
• Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) — SUSPENDED · NA
• Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis — COMPLETED · PHASE1
• Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid — COMPLETED
• The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study. — COMPLETED
• Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis — TERMINATED · PHASE1
• Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) — SUSPENDED · PHASE2
• Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis — ACTIVE_NOT_RECRUITING · PHASE2
• PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer — COMPLETED · NA
• Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC — COMPLETED · NA
• Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. — ACTIVE_NOT_RECRUITING · PHASE3
• Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis — COMPLETED · PHASE1

Refine this search